- Advertisement -

Related

Month in Review – April 2019

- Advertisement -

Stockholm (HedgeNordic) – After enjoying the strongest quarter since early 2015, Nordic hedge funds gained an additional 0.9 percent in April (88 percent reported). On a year-to-date basis, Nordic hedge funds, as expressed by the Nordic Hedge Index, are up 4.0 percent.

Month in Review – April 2019

All five strategy categories in the Nordic Hedge Index performed equally strongly in April. The NHX Equities was up 0.9 percent last month, with mixed returns among its constituents. Equity hedge funds as a group gained 5.0 percent in the first four months of the year. Nordic CTAs gained 1.0 percent on average last month, taking the group’s performance for the year to 1.3 percent. Multi-strategy and fixed-income hedge funds were up 0.9 percent in April. On a year-to-date basis, multi-strategy funds are up 4.4 percent, whereas fixed-income funds gained 3.7 percent. Funds of hedge funds, meanwhile, gained an estimated 0.4 percent in April, extending the group’s 2019 performance to 1.2 percent.

The dispersion between last month’s best and worst performing members of the Nordic Hedge Index widened compared to the prior month. In April, the top 20 percent of hedge funds gained 4.5 percent on average, whereas the bottom 20 percent lost 2.1 percent on average. In the previous month, the top 20 percent was up 3.4 percent on average and the bottom 20 percent lost 2.1 percent. Almost three in every four members of the Nordic Hedge Index posted gains for April.

Rhenman Global Opportunities L/S, a global long/short equity fund that combines a fundamental top-down approach with careful bottom-up analysis, topped last month’s performance leaderboard with a gain of 9.8 percent. The Rhenman fund is up 27.3 percent in the first four months of 2019.

Atlant Sharp and Proxy Renewable Long/Short Energy, two other members of the NHX Equities, gained 7.6 percent and 6.9 percent last month, respectively. Trend-following vehicle Lynx (Sweden) and Nykredit EVIRA were up 6.7 percent and 6.6 percent in April, correspondingly.

 

The Month in Review for April can be downloaded below:

Picture © Sergey-Nivens—shutterstock

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Eugeniu Guzun
Eugeniu Guzun
Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index, and as a journalist covering the Nordic hedge fund industry for HedgeNordic. Eugeniu completed his Master’s degree at the Stockholm School of Economics in 2018. Write to Eugeniu Guzun at eugene@hedgenordic.com

Latest Articles

Stop Making Room for Managed Futures

By Corey Hoffstein, Co-Founder, CEO and CIO at Newfound Research: The case for managed futures as a portfolio diversifier is well established. During the...

Othania Positions Trend-Following at the Core of Multi-Asset Portfolios

Not many investors in the Nordics explicitly allocate to trend-following strategies, yet those who do often regard them as an essential building block in...

Muddling Through the Mess: Managed Futures ETFs

By Alexander Mende and Per Ivarsson at RPM Risk & Portfolio Management: Traditionally, Managed Futures (MF) strategies have been limited to hedge funds known...

There Can Only Be One

By Linus Nilsson of NilssonHedge: In the beginning, CTAs were a cottage industry, focusing on HNW, seeking outsized returns, and deploying notionally funded managed...

SMA Capital Drives Protean Select to Lower Capacity Limit

Since launching Protean Select as an opportunistic long/short equity hedge fund in 2022, Pontus Dackmo and his team have emphasized a clear priority: returns...

Atlas Global Macro Builds on Comeback with New Danish Feeder

Atlas Global Macro, last year’s top-performing Nordic hedge fund, is becoming more accessible to Danish investors through a newly launched feeder fund on the...

Allocator Interviews

In-Depth: Diversification

- Advertisement -

Voices

Request for Proposal

- Advertisement -